Human toxocariasis is one of the most commonly reported zoonotic helminthic infections in the world. In Korea, out of 97 healthy people with over 10% eosinophilia, 60% was positive to Toxocara larvae excretory-secretory (TES) antigen by both immunoblot and ELISA [1]. Also, there was a 0.9% egg positive rate of Toxocara canis out of 662 dogs in a rural area, Korea [2]. Three modes of pathogenesis occur in human toxocariasis. First, T. canis larvae can cause destructive lesions that are characterized by hemorrhage and necrosis during their migration to the eye, liver, lung, brain, and heart [3]. Second, the host immune response against migrating larvae induces inflammation and granuloma formation that is directed to the TES antigen. Third, the TES has been associated with allergy-related syndromes such as chronic urticaria, reactive arthritis, and angioderma, which suggest an allergic reaction to the TES [4]. The excretory-secretory (ES) products of T. canis larvae have been considered as a functional antigen in immune responses against toxocariasis because the excretory cells of the larvae contain many ES products [5]. Then, in most immunological tests, ES recombinant antigens from T. canis second-stage larvae have been conventionally used because the infective Toxocara larvae are extremely difficult to detect in biopsy specimens [6]. Some components of the TES are known to be released from the esophageal gland and lumen, i.e., midbody secretory column, which opens onto the cuticle at a secretory pore, and epicuticle under immunogold electron microscopy [7,8]. Although several studies on the secretory anatomy have been performed in parasitic nematode species [5,9,10], there are no data on the origin of the TES itself in relation to structure and function of the excretory system. We attempted to elucidate the ultrastructural localization of the TES antigen from T. canis second-stage larvae using a human serum that is seropositive against the TES. Determining the distribution sites of the TES will help elucidate the physiologic nature of the TES antigen.For the primary antibody, a human serum that was serologically positive to TES by ELISA and immunoblotting analysis was used. The patient had clinical complaints of visual impairment along with floating or bubbling sensation [11]. For a secondary antibody, goat anti-human IgG ( γ -chain specific) coupled with 5 nm colloidal gold particle (Sigma, St. Louis, Missouri, USA) was used. T. canis larvae from culture media [12] were fixed in 2% paraformaldehyde and 0.4% glutaraldehyde in 0.2 M phosphate buffer (PB, pH 7.4) for 2 hr at room temperature, and washed with 0.2 M PB for 30 min at room temperature. The samples were dehydrated in a graded series of ethanol at 4℃ and embedded in LR gold resin (Electron Microscopy Sciences, Fort Washington, Pennsylvania, USA). The resin was polymerized at -20℃ for 2 days. An ultrathin section (90 nm) was cut and mounted on a 300-mesh nickel grid for labeling (Electron Microscopy Sciences). Sectioned specimens were incubated with drop...